SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-251297
Filing Date
2020-09-22
Accepted
2020-09-22 16:17:02
Documents
13
Period of Report
2020-09-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d47624d8k.htm   iXBRL 8-K 26393
2 EX-99.1 d47624dex991.htm EX-99.1 8456
3 EX-99.2 d47624dex992.htm EX-99.2 50389
7 GRAPHIC g47624g29q37.jpg GRAPHIC 113273
  Complete submission text file 0001193125-20-251297.txt   376112

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20200922.xsd EX-101.SCH 3091
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20200922_lab.xml EX-101.LAB 18071
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20200922_pre.xml EX-101.PRE 11399
8 EXTRACTED XBRL INSTANCE DOCUMENT d47624d8k_htm.xml XML 3332
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 201189751
SIC: 2834 Pharmaceutical Preparations